- Raised Undisclosed Round, Jun 2025
About
NetwoRx Bio is a biotechnology company that aims to transform immunotherapy success rates by deciphering the tumor microenvironment with unprecedented resolution. Its platform maps cell-cell communication across over 30 immune and stromal cell types to guide smarter cancer drug development and generate predictive biomarkers. The company's mechanistic approach aims to reveal all patient's tumor-immune receptor-ligand inhibitory pairs (“brakes”) at every cancer indication, and predict response with minimal samples, enabling successful trials, precise patient enrichment, and faster wins for immuno oncology. NetwoRx Bio operates decentralized biomedical data networks designed for collaborative research and clinical insight generation. The company facilitates secure data exchange across institutions, integrates multi-omics and patient-derived datasets, supports privacy-preserving analytics, enabling researchers, clinicians, and biotech developers to access interoperable resources that accelerate discovery, improve diagnostic precision, and foster scalable innovation in life sciences.
Funding history · 1 round · — total
Q&A
- What is NetwoRx Bio's primary focus?
- NetwoRx Bio is focused on revolutionizing immunotherapy trials by using AI-driven insights to decode communication networks within the tumor microenvironment, aiming to improve treatment response and resistance.
- When was NetwoRx Bio founded?
- NetwoRx Bio was founded in May 2024.
- What is the current employee count for NetwoRx Bio?
- NetwoRx Bio currently has 1-10 employees.
- What technology does NetwoRx Bio utilize?
- NetwoRx Bio utilizes Biologicals and Artificial Intelligence in its operations.
- What is the main product or service offered by NetwoRx Bio?
- NetwoRx Bio generates the NetwoRx Score, a patient-specific metric derived from proprietary clinical trial data and AI analytics, to predict response to various immunotherapeutic treatments.
- What is NetwoRx Bio's current funding stage?
- NetwoRx Bio is currently in the Pre-Funding stage.
- Does NetwoRx Bio hold any patents?
- Yes, NetwoRx Bio holds 1 patent.
- What is NetwoRx Bio's primary sector?
- NetwoRx Bio's primary sector is Health Tech & Life Sciences.
Team · 1
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | networx.bio/ |
|---|---|
| linkedin.com/company/107054316/ |
Identifiers & details
| Former names | Pyxis Dx |
|---|---|
| Founded | 2024 |
| Employees (exact) | 5 |
Radar intelligence
Web history (Wayback)
| Domain | networx.bio |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516007275 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2019-04-02 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 2 — shares_capital (1), people (1) |
| Registered address | רוקח שמעון 1 ירושלים |
Recent registry events
| Date | Event |
|---|---|
| 2025-10-29 | הקצאת מניות |
| 2025-12-09 | עדכון דירקטורים-הסרת דירקטור |